DA Davidson Reaffirms Buy Rating for AMETEK (NYSE:AME)

AMETEK (NYSE:AME)‘s stock had its “buy” rating restated by analysts at DA Davidson in a research note issued on Wednesday,Benzinga reports. They presently have a $240.00 price objective on the technology company’s stock. DA Davidson’s target price points to a potential upside of 5.39% from the stock’s current price.

Several other research firms also recently issued reports on AME. Melius Research set a $235.00 target price on AMETEK in a research report on Monday, January 5th. Weiss Ratings restated a “buy (b)” rating on shares of AMETEK in a research note on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft assumed coverage on shares of AMETEK in a report on Wednesday, January 21st. They set a “buy” rating and a $271.00 target price for the company. KeyCorp upped their price target on shares of AMETEK from $235.00 to $260.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, Robert W. Baird lifted their price objective on AMETEK from $198.00 to $204.00 and gave the company a “neutral” rating in a research note on Monday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $239.27.

AMETEK Stock Down 0.5%

Shares of NYSE AME traded down $1.19 during trading hours on Wednesday, hitting $227.73. 2,259,676 shares of the stock were exchanged, compared to its average volume of 1,401,926. The company has a market cap of $52.42 billion, a PE ratio of 35.92, a PEG ratio of 3.10 and a beta of 1.03. AMETEK has a 12 month low of $145.02 and a 12 month high of $234.56. The company has a quick ratio of 0.72, a current ratio of 1.16 and a debt-to-equity ratio of 0.14. The firm has a fifty day moving average price of $209.02 and a 200-day moving average price of $194.83.

AMETEK (NYSE:AME) last released its quarterly earnings results on Tuesday, February 3rd. The technology company reported $2.01 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.07. AMETEK had a return on equity of 16.66% and a net margin of 20.50%.The company had revenue of $2 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period last year, the business posted $1.87 earnings per share. The firm’s revenue was up 13.4% compared to the same quarter last year. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. On average, sell-side analysts expect that AMETEK will post 7.15 EPS for the current year.

Insider Transactions at AMETEK

In other news, VP Thomas M. Montgomery sold 6,388 shares of the company’s stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $205.05, for a total value of $1,309,859.40. Following the completion of the sale, the vice president directly owned 22,116 shares in the company, valued at $4,534,885.80. This represents a 22.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO David A. Zapico sold 88,000 shares of AMETEK stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $196.39, for a total transaction of $17,282,320.00. Following the sale, the chief executive officer owned 348,955 shares of the company’s stock, valued at approximately $68,531,272.45. This represents a 20.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 137,088 shares of company stock worth $27,212,340 in the last ninety days. Insiders own 0.57% of the company’s stock.

Institutional Investors Weigh In On AMETEK

Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of AMETEK by 0.7% during the third quarter. Vanguard Group Inc. now owns 27,173,705 shares of the technology company’s stock worth $5,108,657,000 after purchasing an additional 176,040 shares in the last quarter. State Street Corp raised its stake in AMETEK by 1.3% during the 3rd quarter. State Street Corp now owns 9,763,684 shares of the technology company’s stock worth $1,835,573,000 after acquiring an additional 126,381 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of AMETEK by 1.8% in the second quarter. Geode Capital Management LLC now owns 5,794,236 shares of the technology company’s stock valued at $1,044,009,000 after acquiring an additional 104,139 shares during the period. Invesco Ltd. boosted its stake in shares of AMETEK by 4.9% during the third quarter. Invesco Ltd. now owns 4,463,518 shares of the technology company’s stock worth $839,141,000 after buying an additional 209,043 shares during the period. Finally, Flossbach Von Storch SE raised its stake in shares of AMETEK by 1.0% during the fourth quarter. Flossbach Von Storch SE now owns 3,820,376 shares of the technology company’s stock worth $784,361,000 after purchasing an additional 36,535 shares during the last quarter. Hedge funds and other institutional investors own 87.43% of the company’s stock.

AMETEK News Summary

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Q4 results beat estimates and revenue grew 13.4% Y/Y — AME reported $2.01 EPS vs. $1.94 consensus and record quarterly and full‑year revenue, driven by broad strength across both operating segments, supporting the company’s growth narrative. Read More.
• Positive Sentiment: Analyst upgrade — KeyCorp raised its price target to $260 and kept an Overweight rating, signaling bullish analyst sentiment and implying material upside from current levels. Read More.
• Positive Sentiment: Strategic tuck‑in acquisition — AMETEK agreed to acquire LKC Technologies (visual electrophysiology/ophthalmic diagnostics), expanding its healthcare/medical instruments exposure and adding product diversification. Read More.
• Neutral Sentiment: 2026 guidance essentially in line but slightly cautious — AME set FY26 EPS at $7.870–8.070 (vs. ~8.00 consensus) and Q1 EPS at $1.85–1.90 (vs. ~1.90 consensus). The guidance is mostly consistent with current expectations but leaves limited upside, which tempers the beat. Read More.
• Negative Sentiment: Analyst caution persists — Morgan Stanley kept a Hold rating with a $215 target, highlighting margin and valuation caution despite resilient revenue trends; mixed analyst views add short‑term volatility risk. Read More.
• Negative Sentiment: Valuation/upgrade risk commentary — Some research notes (e.g., Seeking Alpha) warn AMETEK’s rich valuation could lead to downgrades if margins or growth decelerate, which can pressure the stock despite strong results. Read More.
• Negative Sentiment: Tariff uncertainty flagged — Management flagged tariff-related risks that could depress 2026 profit versus some estimates, a direct near‑term headwind to guidance clarity. Read More.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.